These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33677757)

  • 21. Quantification of phenylalanine hydroxylase activity by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry.
    Heintz C; Troxler H; Martinez A; Thöny B; Blau N
    Mol Genet Metab; 2012 Apr; 105(4):559-65. PubMed ID: 22300847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational spectrum of phenylketonuria in Jiangsu province.
    Chen YF; Jia HT; Chen ZH; Song JP; Liang Y; Pei JJ; Wu ZJ; Wang J; Qiu YL; Liu G; Sun DM; Jiang XY
    Eur J Pediatr; 2015 Oct; 174(10):1333-8. PubMed ID: 25894915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenylalanine hydroxylase gene mutations in the United States: report from the Maternal PKU Collaborative Study.
    Guldberg P; Levy HL; Hanley WB; Koch R; Matalon R; Rouse BM; Trefz F; de la Cruz F; Henriksen KF; Güttler F
    Am J Hum Genet; 1996 Jul; 59(1):84-94. PubMed ID: 8659548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The structural basis of phenylketonuria.
    Erlandsen H; Stevens RC
    Mol Genet Metab; 1999 Oct; 68(2):103-25. PubMed ID: 10527663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation between genotype and phenotype in Swedish phenylketonuria and hyperphenylalaninemia patients.
    Svensson E; von Döbeln U; Eisensmith RC; Hagenfeldt L; Woo SL
    Eur J Pediatr; 1993 Feb; 152(2):132-9. PubMed ID: 8444221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mutant genotype is the main determinant of the metabolic phenotype in phenylalanine hydroxylase deficiency.
    Bénit P; Rey F; Blandin-Savoja F; Munnich A; Abadie V; Rey J
    Mol Genet Metab; 1999 Sep; 68(1):43-7. PubMed ID: 10479481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Genetic Landscape and Epidemiology of Phenylketonuria.
    Hillert A; Anikster Y; Belanger-Quintana A; Burlina A; Burton BK; Carducci C; Chiesa AE; Christodoulou J; Đorđević M; Desviat LR; Eliyahu A; Evers RAF; Fajkusova L; Feillet F; Bonfim-Freitas PE; Giżewska M; Gundorova P; Karall D; Kneller K; Kutsev SI; Leuzzi V; Levy HL; Lichter-Konecki U; Muntau AC; Namour F; Oltarzewski M; Paras A; Perez B; Polak E; Polyakov AV; Porta F; Rohrbach M; Scholl-Bürgi S; Spécola N; Stojiljković M; Shen N; Santana-da Silva LC; Skouma A; van Spronsen F; Stoppioni V; Thöny B; Trefz FK; Vockley J; Yu Y; Zschocke J; Hoffmann GF; Garbade SF; Blau N
    Am J Hum Genet; 2020 Aug; 107(2):234-250. PubMed ID: 32668217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular genetics and impact of residual in vitro phenylalanine hydroxylase activity on tetrahydrobiopterin responsiveness in Turkish PKU population.
    Dobrowolski SF; Heintz C; Miller T; Ellingson C; Ellingson C; Ozer I; Gökçay G; Baykal T; Thöny B; Demirkol M; Blau N
    Mol Genet Metab; 2011 Feb; 102(2):116-21. PubMed ID: 21147011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational spectrum of phenylalanine hydroxylase deficiency in the population resident in Catalonia: genotype-phenotype correlation.
    Mallolas J; Vilaseca MA; Campistol J; Lambruschini N; Cambra FJ; Estivill X; Milà M
    Hum Genet; 1999 Nov; 105(5):468-73. PubMed ID: 10598814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How PAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: insights from in vitro expression.
    Waters PJ
    Hum Mutat; 2003 Apr; 21(4):357-69. PubMed ID: 12655545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in exon 3 of the PAH gene causing mild hyperphenylalaninemia.
    Zekanowski C; Nowacka M; Gizewska M; Filipowicz J; Cabalska B; Bal J
    Genet Test; 1999; 3(3):297-9. PubMed ID: 10495930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of PAH gene variants among a population of Han Chinese patients with phenylketonuria from northern China.
    Liu N; Huang Q; Li Q; Zhao D; Li X; Cui L; Bai Y; Feng Y; Kong X
    BMC Med Genet; 2017 Oct; 18(1):108. PubMed ID: 28982351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward mechanistic models for genotype-phenotype correlations in phenylketonuria using protein stability calculations.
    Scheller R; Stein A; Nielsen SV; Marin FI; Gerdes AM; Di Marco M; Papaleo E; Lindorff-Larsen K; Hartmann-Petersen R
    Hum Mutat; 2019 Apr; 40(4):444-457. PubMed ID: 30648773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of the long non-coding RNA (lncRNA) transcript HULC for the regulation of phenylalanine hydroxylase and treatment of phenylketonuria.
    Lin C; Li Y; Zhang E; Feillet F; Zhang S; Blau N
    Mol Genet Metab; 2022 Mar; 135(3):171-178. PubMed ID: 35101330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenylketonuria: genotype-phenotype correlations based on expression analysis of structural and functional mutations in PAH.
    Pey AL; Desviat LR; Gámez A; Ugarte M; Pérez B
    Hum Mutat; 2003 Apr; 21(4):370-8. PubMed ID: 12655546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PKU mutation G46S is associated with increased aggregation and degradation of the phenylalanine hydroxylase enzyme.
    Eiken HG; Knappskog PM; Apold J; Flatmark T
    Hum Mutat; 1996; 7(3):228-38. PubMed ID: 8829656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular epidemiology of phenylalanine hydroxylase deficiency in Southern Italy: a 96% detection rate with ten novel mutations.
    Daniele A; Cardillo G; Pennino C; Carbone MT; Scognamiglio D; Correra A; Pignero A; Castaldo G; Salvatore F
    Ann Hum Genet; 2007 Mar; 71(Pt 2):185-93. PubMed ID: 17096675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational spectrum of phenylalanine hydroxylase deficiency in Sicily: implications for diagnosis of hyperphenylalaninemia in southern Europe.
    Guldberg P; Romano V; Ceratto N; Bosco P; Ciuna M; Indelicato A; Mollica F; Meli C; Giovannini M; Riva E
    Hum Mol Genet; 1993 Oct; 2(10):1703-7. PubMed ID: 8268925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An update of the mutation spectrum of phenylalanine hydroxylase (PAH) gene in the population of Turkey.
    Ozturk FN; Akin Duman T
    J Pediatr Endocrinol Metab; 2022 May; 35(5):663-668. PubMed ID: 35405047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of phenylketonuria in Japanese patients.
    Okano Y; Asada M; Kang Y; Nishi Y; Hase Y; Oura T; Isshiki G
    Hum Genet; 1998 Nov; 103(5):613-8. PubMed ID: 9860305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.